[HTML][HTML] SARS-CoV-2 variants, vaccines, and host immunity

P Mistry, F Barmania, J Mellet, K Peta… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus
that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes …

[HTML][HTML] COVID-19: challenges of viral variants

JL Jacobs, G Haidar, JW Mellors - Annual Review of Medicine, 2023 - annualreviews.org
The COVID-19 pandemic has been accompanied by SARS-CoV-2 evolution and
emergence of viral variants that have far exceeded initial expectations. Five major variants of …

COVID-19 in patients with hematologic malignancy

P Langerbeins, M Hallek - Blood, The Journal of the American …, 2022 - ashpublications.org
The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic
heterogeneity. Several risk factors including advanced age, previous illnesses, and a …

[HTML][HTML] Immunocompromised patients with protracted COVID-19: a review of “long persisters”

V Dioverti, S Salto-Alejandre, G Haidar - Current transplantation reports, 2022 - Springer
Abstract Purpose of Review Certain immunocompromised individuals are at risk for
protracted COVID-19, in which SARS-CoV-2 leads to a chronic viral infection. However, the …

Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside

JC Laracy, M Kamboj, SA Vardhana - Current opinion in infectious …, 2022 - journals.lww.com
Persistent COVID-19 infection is a unique concern in patients with hematologic
malignancies. While vaccination against severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review

D Hettle, S Hutchings, P Muir, E Moran… - Clinical Infection in …, 2022 - Elsevier
Background Most patients with SARS-CoV-2 are non-infectious within 2 weeks, though viral
RNA may remain detectable for weeks. However there are reports of persistent SARS-CoV-2 …

SARS-CoV-2 in immunocompromised individuals

S DeWolf, JC Laracy, MA Perales, M Kamboj… - Immunity, 2022 - cell.com
Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …

[HTML][HTML] Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era

T Zhang, W Tian, S Wei, X Lu, J An, S He… - … Hematology & Oncology, 2023 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) posed an unprecedented challenge
on public health systems. Despite the measures put in place to contain it, COVID-19 is likely …

[HTML][HTML] Long-term monitoring of SARS-CoV-2 variants in wastewater using a coordinated workflow of droplet digital PCR and nanopore sequencing

K Vigil, N D'Souza, J Bazner, FMA Cedraz, S Fisch… - Water Research, 2024 - Elsevier
Quantitative polymerase chain reaction (PCR) and genome sequencing are important
methods for wastewater surveillance of severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] SARS-CoV-2 evolution and spike-specific CD4+ T-cell response in persistent COVID-19 with severe HIV immune suppression

H Álvarez, E Ruiz-Mateos, PM Juiz-González, J Vitallé… - Microorganisms, 2022 - mdpi.com
Intra-host evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
been reported in cases with persistent coronavirus disease 2019 (COVID-19). In this study …